American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015

Abstract

Abbreviations:A1Chemoglobin A1cAACEAmerican Association of Clinical EndocrinologistsACCORDAction to Control Cardiovascular Risk in DiabetesACEangiotensin-converting enzymeADAAmerican Diabetes AssociationADVANCEAction in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled EvaluationAERalbumin excretion rateAPOBapolipoprotein BARBangiotensin II receptor blockerASCVDatherosclerotic cardiovascular diseaseBElbest evidence levelBMIbody mass indexCDCCenters for Disease Control and PreventionCDEcertified diabetes educatorCGMcontinuous glucose monitoringCKDchronic kidney diseaseCPAPcontinuous positive airway pressureCPGclinical practice guidelineCSIIcontinuous subcutaneous insulin infusionCVDcardiovascular diseaseDCCTDiabetes Control and ComplicationsDKAdiabetic ketoacidosisDMdiabetes mellitusDPPDiabetes Prevention ProgramDPP-4dipep-tidyl peptidase 4DSMEdiabetes self-management educationDSPNdistal symmetric polyneuropathyElevidence levelESRDend-stage renal diseaseFDAU.S. Food and Drug AdministrationFPGfasting plasma glucoseGDMgestational diabetes mellitusGFRglomerular filtration rateGIgastrointestinalGLP-1glucagon-like peptide 1HBVhepatitis B virusHDL-Chigh-density lipoprotein cholesterolHRhazard ratioICUintensive care unitIFGimpaired fasting glucoseIGTimpaired glucose toleranceISFinsulin sensitivity factorLDL-Clow-density lipoprotein cholesterolLDL-plow-density lipoprotein particlesLOOK AHEADLook Action for Health in DiabetesMDImultiple daily injectionsMNTmedical nutrition therapyNPHneutral protamine HagedornOGTToral glucose tolerance testOSAobstructive sleep apneaPGplasma glucosePOCpoint-of-carePPGpostprandial glucosePTHparathyroid hormoneQclinical questionRrecommendationRAASrenin-angiotensin-aldosterone systemRCTrandomized controlled trialSFNsmall-fiber neuropathySGLT2sodium glucose cotransporter 2SMBGself-monitoring of blood glucoseT1Dtype 1 diabetesT2Dtype 2 diabetesTZDthiazolidinedioneUKPDSUnited Kingdom Prospective Diabetes StudyVADTVeterans Affairs Diabetes Trial hemoglobin A1c American Association of Clinical Endocrinologists Action to Control Cardiovascular Risk in Diabetes angiotensin-converting enzyme American Diabetes Association Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation albumin excretion rate apolipoprotein B angiotensin II receptor blocker atherosclerotic cardiovascular disease best evidence level body mass index Centers for Disease Control and Prevention certified diabetes educator continuous glucose monitoring chronic kidney disease continuous positive airway pressure clinical practice guideline continuous subcutaneous insulin infusion cardiovascular disease Diabetes Control and Complications diabetic ketoacidosis diabetes mellitus Diabetes Prevention Program dipep-tidyl peptidase 4 diabetes self-management education distal symmetric polyneuropathy evidence level end-stage renal disease U.S. Food and Drug Administration fasting plasma glucose gestational diabetes mellitus glomerular filtration rate gastrointestinal glucagon-like peptide 1 hepatitis B virus high-density lipoprotein cholesterol hazard ratio intensive care unit impaired fasting glucose impaired glucose tolerance insulin sensitivity factor low-density lipoprotein cholesterol low-density lipoprotein particles Look Action for Health in Diabetes multiple daily injections medical nutrition therapy neutral protamine Hagedorn oral glucose tolerance test obstructive sleep apnea plasma glucose point-of-care postprandial glucose parathyroid hormone clinical question recommendation renin-angiotensin-aldosterone system randomized controlled trial small-fiber neuropathy sodium glucose cotransporter 2 self-monitoring of blood glucose type 1 diabetes type 2 diabetes thiazolidinedione United Kingdom Prospective Diabetes Study Veterans Affairs Diabetes Trial